This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Humans are diverse and communications to engage us need to be inclusive. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected. Today, people are culturally, socially, and demographically diverse.
Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected by the changing world of digital communication. Fundamentally, the aims of healthcare communication haven’t changed, panellists said. And I think that’s changing a lot the way that we do communication.”.
Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Creating a more informed patient can improve outcomes and ultimately, quality of life. Patient focus.
Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. For more information, visit veeva.com/eu. The post 4 ways to embed data-driven best practice in pharma HCP communications appeared first on.
Content metrics is the collection of content data for both the industry as a benchmark and the individual company’s content performance,’’ says Ian. “It It informscompanies how its content is created, approved, reused and published and how to optimise performance for a more significant impact. Every country has its regulations.
Table of Contents: Understanding Pharma Tariffs Impacts on Branded Drug Marketing Adjusting Digital Advertising Strategies Strategic Recommendations for Pharma Marketers Conclusion FAQs Understanding Pharma Tariffs Pharma tariffs are taxes imposed by governments on imported pharmaceutical products. How do pharma tariffs impact drug pricing?
Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.
Medical affairs is the bridge between pharmaceuticalcompanies and healthcare providers. It includes roles like Medical Science Liaisons (MSLs), who engage with providers, and Medical Information Specialists, who answer complex drug-related questions. Once youve narrowed your focus, communication becomes the next hurdle.
It’s like a bridge connecting the intricate world of medical science to everyday healthcare communication. In an era where accurate and timely information can critically impact patient outcomes, effective communication in healthcare becomes paramount. Scary thought, right?
Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. This webinar will also explore: How the changing nature of communications technology and modalities are changing the MSL’s role.
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
There is little doubt that the arrival of COVID-19 changed the game for communication and commercialisation efforts for pharmaceuticalcompanies around the world. Today’s pharmaceutical ads have come a long way since the days of snake oil and miracle elixirs. Inside the colourful history of pharma advertising.
COVID-19 might have forced pharma to finally fully embrace digital communications, but that doesn’t mean the industry is good at using these platforms yet. Getting information to time-poor HCPs can be incredibly difficult. Ian Daley and Jonathan Macdonald from EPG Health tell us how pharma can take cues from companies like Amazon.
Companies are also helping patients understand where they can access labs, infusion centres or imaging centres, and are offering solutions to HCPs and their practices so they can more easily afford and keep stock of therapies. The impact on launch.
The new General Practice Data for Planning and Research (GPDPR) service was unveiled earlier this month by NHS Digital, which described it as a way to “improve” the collection of patient information that would allow better planning of healthcare services and use of data in medical research.
Companies are investing heavily in digital tools to streamline communication and build stronger connections. Strategies like storytelling, personalized educational content, and two-way communication channels create trust and build loyalty. Patient-Centric Marketing Patients want to feel heard.
In February 2019, Viseven, a global provider of digital solutions for the life sciences industry, announced a strategic collaboration with a global pharmaceuticalcompany. This company specializes in biopharmaceuticals, diabetes care, obesity care, and other severe chronic diseases. Let us know!
Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceuticalcompanies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceuticalcompanies and patient and caregivers.”.
Developing strong and meaningful relationships with Healthcare Professionals (HCPs) is vital for healthcare organizations, pharmaceuticalcompanies, and medical device manufacturers alike. Effective Communication: The foundation of any successful relationship is clear and effective communication.
Content metrics is the collection of data related to an industry or a company’s content. It informscompanies how its content is received and how to optimise performance for a more significant impact. For more information, visit veeva.com/eu.
Here are some factors to consider when choosing a web development company for the pharmaceutical industry: ● Experience in the pharmaceutical industry: Make sure the company you choose has experience developing websites for pharmaceuticalcompanies. Interview multiple companies before making a decision. ●
Trend #1: Media and Tech: Facilitating Communication. The pharmaceutical industry is making it a high priority to be transparent with their audience and help their patients feel as comfortable as possible while getting the care they need. Trend #4: Questioning the Systems: Doubt in Institutions.
Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). In the age of information overload, we all know that it is essential to add ‘value’ if we are to cut through the noise. And therein lies an issue.
The pandemic has triggered a change in how pharmaceuticalcompanies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceuticalcompany engagement during the crisis. The answer was yes.
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. What are the key points from the Guidance?
In order to test, market, and release drugs onto the market, pharmaceuticalcompanies must abide by government regulations and oversight processes. . Regulatory affairs, however, encompasses more than just the pharmaceutical industry. Pharmacists who work in the private sector typically work for a pharmaceuticalcompany.
People can opt out of the scheme by filling in a form and taking it to their GP, but campaigners have complained that this was not communicated effectively and could place an onerous workload on GPs already battling to provide care amid the pandemic. Professor Michie sits on SAGE.
Only 33% of the UK public would trust pharmaceuticalcompanies to keep their health data secure – whilst, for instance, 89% trust information from traditional healthcare providers – such as doctors and hospitals. There are plans by the UK health sector containing bold proposals to modernise patient information storage.
Despite the success tied to the vaccine rollout, analysing data is still a daily challenge for many life sciences and pharmaceuticalcompanies. One example of this use case is a pharmaceuticalcompany that recently gained FDA approval for a rare cancer treatment. and consulting roles.
However, the Resilience Project’s scientists had used genomic data originally collected for other studies and, due to limitations in the original studies’ informed consent policies and a lack of infrastructure to recontact participants, none of the 13 individuals could be contacted with follow-up questions or requests.
To combat such challenges, pharmaceuticalcompanies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceuticalcompanies can ensure drug production runs smoothly – even under stress.
Medical affairs in Pharma are often seen as a central agency that works within a healthcare company and prioritize communication among life science organizations, medical professionals, healthcare providers, and patients. Medical affairs definition uses clinical and scientific information to communicate the efficiency of a drug.
Just as the wider healthcare system continues to acclimate to a new normal, the way pharma and physicians communicate is experiencing a technological revolution. Inefficient communications pre-COVID. I still have a stack of business cards with the information of 20-30 different pharmaceutical and medical device reps,” said Dr. Mehra.
” To stay relevant, sales reps need to have accurate, up-to-date information about their audience, stand out among competitors in the crowded digital space, and make their communications more impactful. And limitations from some data providers on where and how companies can use data hinder rep productivity. .”
Pharmaceuticalcompanies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health.
In an era where medicine is rapidly becoming more personalized, why do pharmaceuticalcompanies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceuticalcompanies, creating a unique opportunity to build trust with patients.
In an increasingly competitive pharmaceutical landscape, the significance of healthcare branding has never been more pronounced. As we approach 2025, the ability of pharmaceuticalcompanies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success.
In the digital age, content creation for social media has become an indispensable tool for industries across the board, including pharmaceuticals. As the healthcare landscape evolves, pharmaceuticalcompanies are increasingly leveraging social media platforms to connect with healthcare professionals, patients, and the broader public.
A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceuticalcompanies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
Understanding Influencer Networks in Pharma Influencer networks in the pharmaceutical industry differ significantly from those in other sectors due to the highly regulated nature of healthcare communications. This includes clear disclosures of any financial or material relationships between the influencer and the brand.
Physicians, patients, and caregivers are all tapping into the power of social media to communicate with one another and increase awareness about certain issues that are important to them. There are numerous benefits for pharmaceuticalcompanies in the healthcare influencer space.
In the rapidly evolving pharmaceutical industry, building a robust pharma network is crucial for companies aiming to expand their influence and stay competitive. A well-connected network can facilitate the dissemination of information, enhance collaborative efforts, and ultimately drive growth.
Funders’ investments can boost healthcare efficiency and effectiveness when benefactors are fully informed about the healthcare systems in which they strive to make a change. That can help inform efficiency in best understanding what pharmaceutical commodities are in demand. Pharma’s role.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content